🇺🇸 Daily rifapentine and isoniazid for 4 weeks in United States

Daily rifapentine and isoniazid for 4 weeks (Daily rifapentine and isoniazid for 4 weeks) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Daily rifapentine and isoniazid for 4 weeks in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Daily rifapentine and isoniazid for 4 weeks approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Daily rifapentine and isoniazid for 4 weeks in United States?

The Aurum Institute NPC is the originator. The local marketing authorisation holder may differ — check the official source linked above.